Learn how sleep apnoea and high blood glucose are linked, what CPAP research can tell us, and which symptoms deserve a GP or sleep specialist review.

In short
From Vively member data
Obstructive sleep apnoea is linked with insulin resistance and type 2 diabetes, and it can make glucose management harder. Repeated breathing interruptions disrupt sleep and oxygen delivery. Treating apnoea matters for sleep and health, but the glucose response varies. A high reading alone cannot tell you whether you have this sleep disorder.
If you are waking unrefreshed or someone has noticed breathing pauses, take those symptoms to your GP. You do not need to wait for an abnormal glucose test before asking for help.
Obstructive sleep apnoea occurs when the upper airway repeatedly narrows or closes during sleep. Airflow falls or stops, and the sleeping brain briefly rouses the body to reopen the airway. You may not remember these interruptions the next day.
Central sleep apnoea has a different mechanism: the brain's signals to the breathing muscles are disrupted. The two conditions require clinical assessment. This article focuses on obstructive sleep apnoea, usually shortened to OSA, because that is the form most often studied alongside type 2 diabetes.
Snoring can accompany OSA, but snoring alone does not establish the diagnosis. Other signs include witnessed breathing pauses, choking or gasping, morning headache and excessive daytime sleepiness. Some people notice fatigue or difficulty concentrating rather than obvious sleepiness. Symptoms can overlap with other health conditions.
Repeated oxygen drops and sleep disruption can interfere with glucose regulation, while shared risk factors also help explain the association. A connection between two conditions does not mean every high glucose result is caused by apnoea.
Interrupted sleep can activate the sympathetic nervous system, the body's alerting response. Alongside changes in stress-hormone signalling, this may reduce how effectively insulin works. Insulin resistance means the body needs more insulin to handle the same amount of glucose. Our explanation of insulin resistance and insulin sensitivity covers the wider context.
OSA and type 2 diabetes also share risk factors, including higher body fat, so observational research can be difficult to interpret. Researchers must account for those factors before attributing a glucose difference to breathing interruptions. In an NIDDK discussion of sleep and diabetes, sleep researcher Eve Van Cauter explains how insufficient, irregular and disrupted sleep can affect glucose tolerance.
These mechanisms are plausible, but they do not identify the cause of an individual's result. Food, medicines, infection, sleep timing and established diabetes can all contribute. A blood glucose result should be interpreted with its timing, test method and clinical history.
CPAP may improve glucose measures in some people with OSA and type 2 diabetes, but clinical trials have produced mixed results. It should not be presented as a guaranteed way to lower blood glucose or replace diabetes treatment.
Continuous positive airway pressure, or CPAP, sends air through a mask to help keep the airway open during sleep. Its purpose is to treat the breathing disorder. Whether a glucose measure changes is a separate question, affected by the population studied, baseline diabetes management and how consistently the device is used.
Herth and colleagues' 2023 systematic review of randomised trials in people with both OSA and type 2 diabetes found an improvement in HbA1c with CPAP compared with inactive control treatment. Greater nightly use was associated with a larger improvement. That is evidence of a possible benefit in this group, rather than a promise for each person.
A broader 2023 randomised-trial review by Cattazzo and colleagues found small improvements in some insulin measures, without a reduction in HbA1c across its OSA population. A Danish randomised trial published in 2021 found no significant improvement in its continuous-monitoring glucose outcomes. The different findings are a reason to describe the evidence cautiously.
Use CPAP as prescribed even if your next glucose result does not change. If the mask is uncomfortable, leaks or comes off overnight, ask the sleep service to review it. The treatment team can address fit and other barriers. Do not stop or reduce diabetes medicines because you have started CPAP. Tell your diabetes team about suspected overnight lows as well. Our guide to low blood sugar at night explains the symptoms and care-plan questions to discuss.
A sleep study assesses breathing during sleep, while appropriate blood tests assess glucose regulation. Neither test substitutes for the other.
| Assessment | What it can assess | What it cannot establish alone |
|---|---|---|
| Clinical history and sleep study | Breathing interruptions, oxygen changes and the type of sleep disorder | Whether a person has diabetes |
| Fasting glucose or HbA1c | Glucose regulation, interpreted under diagnostic guidance | Whether the airway obstructs during sleep |
| Consumer sleep or glucose trends | Information to discuss alongside symptoms and clinical results | A diagnosis of OSA or diabetes |
Your GP will ask about sleepiness, sleep routines, medicines and other health conditions. A partner's observations can be helpful, with your permission. Depending on the findings, a clinician may refer you for a sleep study or specialist review. Consumer sleep scores and overnight oxygen estimates need confirmation through appropriate assessment.
If diabetes is suspected, a GP may arrange a fasting glucose test, an HbA1c test or another investigation. Follow the preparation instructions and discuss anything that could affect interpretation, including pregnancy, anaemia or recent illness.
A glucose sensor can show overnight trends for someone whose clinician recommends it, but a high sensor trace does not reveal whether the airway was blocked. Our guide to blood tests and continuous glucose monitoring explains how these measurements differ. Avoid trying to diagnose apnoea from a glucose graph.
Care works best when the sleep service, GP and diabetes team know about each other's findings and treatment plans. Each condition still needs follow-up in its own right.
Tell the sleep team about diabetes and tell the diabetes team about OSA, including any treatment difficulties. Keep a current medicine list. If you are having surgery or sedation, make sure the procedural team knows about your sleep apnoea and any breathing device you use.
Regular sleep times and a suitable sleep environment can support rest. Advice about alcohol, smoking, movement or weight should be tailored to your situation. Our sleep-hygiene guide can help you prepare questions, but those habits do not remove an airway obstruction or replace prescribed treatment.
Ask how treatment effectiveness will be checked. This can include symptom review, device data or a repeat sleep assessment when indicated. For glucose, use the follow-up schedule agreed with your GP. Review each trend separately so an improvement in tiredness is not mistaken for proof that diabetes has resolved.
Sleepiness that affects driving or other safety-sensitive activities needs prompt medical advice. Do not drive when sleepy, and discuss any near misses or unintended dozing with your GP.
Seek urgent medical care for severe breathlessness, chest pain, confusion or serious illness. High glucose with vomiting, abdominal pain or difficult breathing also needs urgent assessment under your diabetes emergency plan. These symptoms should not be attributed to a poor night's sleep without checking.
No. Sleep apnoea and type 2 diabetes are associated, but either can occur without the other. Shared risk factors and the effects of disrupted sleep help explain the relationship. Your GP decides whether glucose testing is appropriate from your symptoms, history and existing results, rather than assuming diabetes from snoring.
No. High glucose has several possible causes and does not show what happened to your breathing overnight. Suspected apnoea needs a clinical assessment and, when indicated, a sleep study. Mention witnessed breathing pauses, gasping and daytime sleepiness even if your glucose tests are within the laboratory range.
No. CPAP treats airway obstruction during sleep. Some research suggests a glucose benefit in people who also have type 2 diabetes, but results differ between studies and individuals. Keep taking diabetes medicines as prescribed and ask your treating team before making any change to their amount or timing.
No. A consumer device's sleep score cannot reliably rule out a breathing disorder. It may provide useful context about your routine, but persistent symptoms still deserve a GP review. Ask about assessment if someone notices breathing pauses or you remain excessively sleepy despite allowing enough time for sleep.
The Baseline Health Check is a blood test covering 70+ markers at one of 3,700+ collection centres. Your dietitian goes through your results with you and builds your plan. $99$79 this Black Friday, ends 1 Dec. Then $99 a month, cancel anytime.